← Back to headlines
Zevra Therapeutics to Present Long-Term Data on MIPLYFFA for Niemann-Pick Disease
Zevra Therapeutics will showcase new real-world evidence regarding MIPLYFFA treatment outcomes for Niemann-Pick Disease Type C patients at the upcoming 2026 SSIEM Annual Symposium.
25 Aug, 11:30 — 25 Aug, 11:30
Related Stories
Fundraising Campaign Launched to Cover Rehabilitation Costs for Paralyzed Bosnian Man
42m ago
French Court Links Flight Attendant's Breast Cancer to Cosmic Radiation
50m ago
Dutch Health Officials Confirm First Local West Nile Virus Cases
2h ago
Mother and Daughter Die After Rain-Triggered Wall Collapse in Spain
3h ago